Examining the True Prevalence of Hypercortisolism and Its Impact on Managing Resistant Diabetes : Episode 1
Overview of the CATALYST Study for Hypercortisolism
The CATALYST study is discussed by a panel of experts led by Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES.
Now Viewing
EP: 1.Overview of the CATALYST Study for Hypercortisolism
EP: 2.Defining Difficult to Control Diabetes
EP: 3.CATALYST Trial Study Design
EP: 4.True Prevalence of Hypercortisolism
EP: 5.Coexisting Cardiometabolic Conditions and Hypercortisolism
EP: 6.Engaging Primary Care Clinicians in Screening for Hypercortisolism
EP: 7.Spectrum of Hypercortisolism Presentations
EP: 8.Mifeprestone for Treatment of Hypercortisolism
EP: 9.Reconsidering Standard of Care for Hypercortisolism
Video content above is prompted by the following:
- What is the significance of the CATALYST trial? Can you explain the rationale for the study?
Recent Videos
